Kythera Biopharmaceuticals
Focuses on the discovery, development, and commercialization of prescription products for the aesthetic medicine market in the United States and internationally.
Employees
Enterprise value
$2.1b
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
$2.1b Valuation: $2.1b | Acquisition | ||
| Total Funding | 000k | ||
Versant Ventures(exited)
ARCH Venture Partners(exited)
Altitude Life Science Ventures(exited)
Prospect Venture Partners(exited)
Wilson Sonsini(exited)
WS Investments(exited)
BB&T(exited)
Jafco Life Science(exited)
Apothecary Capital(exited)
Latham & Watkins(exited)
Invus(exited)
Foley Ventures(exited)
UCLA VC Fund(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads